Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 3, Double-blind, Randomized, Placebo controlled, Multicenter Study of GBT440 Administered Orally to Patients with Sickle Cell Disease
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.